WILLIAM A. OSBORN - 26 Oct 2021 Form 4 Insider Report for ABBOTT LABORATORIES (ABT)

Role
Director
Signature
/s/ William A. Osborn by Jessica H. Paik, Attorney-in-Fact
Issuer symbol
ABT
Transactions as of
26 Oct 2021
Net transactions value
+$935,984
Form type
4
Filing time
27 Oct 2021, 18:37:09 UTC
Next filing
03 May 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ABT Common shares without par value Options Exercise $935,984 +15,752 +19% $59.42 96,996 26 Oct 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ABT Option (right to buy) Options Exercise $0 -15,752 -100% $0.000000* 0 26 Oct 2021 Common Shares 15,752 $59.42 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.